litlas
Log inCreate account

Philip D. Gregory

Active 1997–2024

89
Papers
36,252
Citations
82
h-index
88
i10-index

Citations

Citations per year for Philip D. Gregory1991: 1 citations1997: 2 citations1998: 4 citations1999: 9 citations2000: 23 citations2001: 26 citations2002: 27 citations2003: 37 citations2004: 34 citations2005: 72 citations2006: 74 citations2007: 66 citations2008: 120 citations2009: 199 citations2010: 350 citations2011: 494 citations2012: 678 citations2013: 891 citations2014: 914 citations2015: 926 citations2016: 716 citations2017: 612 citations2018: 476 citations2019: 1,216 citations2020: 1,124 citations2021: 1,117 citations2022: 814 citations2023: 564 citations2024: 801 citations2025: 397 citations2026: 7 citations1992–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,867 citing papers, 33.7% of this breakdownChina: 1,074 citing papers, 9.3% of this breakdownUnited Kingdom: 747 citing papers, 6.5% of this breakdownGermany: 719 citing papers, 6.3% of this breakdownFrance: 476 citing papers, 4.1% of this breakdownJapan: 351 citing papers, 3.1% of this breakdownItaly: 339 citing papers, 2.9% of this breakdownCanada: 302 citing papers, 2.6% of this breakdownIndia: 291 citing papers, 2.5% of this breakdownAustralia: 272 citing papers, 2.4% of this breakdownNetherlands: 264 citing papers, 2.3% of this breakdownSwitzerland: 236 citing papers, 2.1% of this breakdown
0%33.7%Other 22.2%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology63.9%
  • Medicine24.6%
  • Immunology and Microbiology4.1%
  • Neuroscience2.2%
  • Agricultural and Biological Sciences2%
  • Physics and Astronomy1.1%
  • Other2.1%

Topics

  • CRISPR and Genetic Engineering13.9%
  • Virus-based gene therapy research4.3%
  • CAR-T cell therapy research3.8%
  • Genomics and Chromatin Dynamics3.7%
  • Pluripotent Stem Cells Research3.5%
  • Epigenetics and DNA Methylation2.8%
  • Other68%

Coauthors

All papers

Open in search
  1. Genome editing with engineered zinc finger nucleases

    Authors: Fyodor D. Urnov, Edward J. Rebar, Michael C. Holmes, H. Steve Zhang, Philip D. Gregory - Nature Reviews Genetics 2010 cited by 2,267

  2. A TALE nuclease architecture for efficient genome editing

    Authors: Jeffrey C. Miller, Siyuan Tan, Guijuan Qiao, Kyle A. Barlow, Jianbin Wang, Danny F. Xia, Xiangdong Meng, David E. Paschon, Elo Leung, Sarah J. Hinkley, Gladys P Dulay, Kevin Hua, Irina Ankoudinova, Gregory J. Cost, Fyodor D. Urnov, H Steve Zhang, Michael C. Holmes, Lei Zhang, Philip D. Gregory, Edward J. Rebar - Nature Biotechnology 2010 cited by 2,093

  3. Off-the-shelf, steroid-resistant, IL13Rα2-specific CAR T cells for treatment of glioblastoma

    Authors: Christine E. Brown, Analiz Rodriguez, Joycelynne Palmer, Julie R. Ostberg, Araceli Naranjo, Jamie R. Wagner, Brenda Aguilar, Renate Starr, Lihong Weng, Timothy W. Synold, Vivi Tran, Shelley Wang, Andreas Reik, Massimo D’Apuzzo, Julie A. Ressler, Yuanyue Zhou, Matthew Mendel, Philip D. Gregory, Michael C. Holmes, Winson W. Tang, Stephen J. Forman, Michael C. Jensen, Behnam Badie - Neuro-Oncology 2022 cited by 143

  4. Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV

    Authors: Pablo Tebas, David Stein, Winson W. Tang, Ian Frank, Shelley Q. Wang, Gary Lee, S. Kaye Spratt, Richard Surosky, Martin Giedlin, Geoff Nichol, Michael C. Holmes, Philip D. Gregory, Dale Ando, Michael Kalos, Ronald G. Collman, Gwendolyn Binder-Scholl, Gabriela Plesa, Wei‐Ting Hwang, Bruce L. Levine, Carl H. June - New England Journal of Medicine 2014 cited by 1,348

  5. Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease

    Authors: Sunita Goyal, John Tisdale, Manfred Schmidt, Julie Kanter, Jennifer Jaroscak, Dustin Whitney, Hans Bitter, Philip D. Gregory, Geoffrey Parsons, Marianna Foos, Ashish Yeri, Maple Gioia, Sarah B. Voytek, Alex Miller, Jessie Lynch, Richard A. Colvin, Melissa Bonner - New England Journal of Medicine 2021 cited by 193

  6. A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR

    Authors: Hiroki Torikai, Andreas Reik, Pei-Qi Liu, Yuanyue Zhou, Ling Zhang, Sourindra N. Maiti, Helen Huls, Jeffrey C. Miller, Partow Kebriaei, Brian Rabinovitch, Dean A. Lee, Richard E. Champlin, Chiara Bonini, Luigi Naldini, Edward J. Rebar, Philip D. Gregory, Michael C. Holmes, Laurence J.N. Cooper - Blood 2012 cited by 521

  7. Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic Regions

    Authors: Aaron D. Goldberg, Laura A. Banaszynski, Kyung‐Min Noh, Peter W. Lewis, Simon J. Elsaesser, Sonja C. Stadler, Scott Dewell, Martin J. Law, Xingyi Guo, Xuan Li, Duancheng Wen, Ariane Chapgier, Russell C. DeKelver, Jeffrey C. Miller, Ya-Li Lee, Elizabeth A. Boydston, Michael C. Holmes, Philip D. Gregory, John M. Greally, Shahin Rafii, Chingwen Yang, Peter Scambler, David Garrick, Richard J. Gibbons, Douglas R. Higgs, Ileana M. Cristea, Fyodor D. Urnov, Deyou Zheng, C. David Allis - Cell 2010 cited by 1,292

  8. Controlling Long-Range Genomic Interactions at a Native Locus by Targeted Tethering of a Looping Factor

    Authors: Wulan Deng, Jongjoo Lee, Hong‐Xin Wang, Jeff F. Miller, Andreas Reik, Philip D. Gregory, Ann Dean, Gerd A. Blobel - Cell 2012 cited by 767

  9. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates

    Authors: Judith Straimer, Nina F. Gnädig, Benoît Witkowski, Chanaki Amaratunga, Valentine Duru, Arba Pramundita Ramadani, Mélanie Dacheux, Nimol Khim, Lei Zhang, Stephen C.-T. Lam, Philip D. Gregory, Fyodor D. Urnov, Odile Mercereau‐Puijalon, Françoise Benoit‐Vical, Rick M. Fairhurst, Didier Ménard, David A. Fidock - Science 2014 cited by 751

  10. Highly efficient endogenous human gene correction using designed zinc-finger nucleases

    Authors: Fyodor D. Urnov, Jeffrey C. Miller, Ya-Li Lee, Christian Beauséjour, Jeremy M. Rock, Sheldon Augustus, Andrew C. Jamieson, Matthew H. Porteus, Philip D. Gregory, Michael C. Holmes - Nature 2005 cited by 1,644

  11. Allele-selective transcriptional repression of mutant HTT for the treatment of Huntington’s disease

    Authors: Bryan Zeitler, Steven Froelich, Kimberly Marlen, David A. Shivak, Qi Yu, Davis Li, Jocelynn R. Pearl, Jeffrey C. Miller, Lei Zhang, David E. Paschon, Sarah J. Hinkley, Irina Ankoudinova, Stephen C.-T. Lam, Dmitry Guschin, Lexi Kopan, Jennifer M. Cherone, Hoang-Oanh B. Nguyen, Guijuan Qiao, Yasaman Ataei, Matthew Mendel, Rainier Amora, Richard Surosky, Josée Laganière, B. Joseph Vu, Anand Narayanan, Yalda Sedaghat, Karsten Tillack, Christina Thiede, Annette Gärtner, Seung Kwak, Jonathan Bard, Ladislav Mrzljak, Larry Park, Taneli Heikkinen, Kimmo Lehtimäki, Marie Svedberg, Jenny Häggkvist, Lenke Tari, Miklós Tóth, Andrea Varrone, Christer Halldin, Andrea E. Kudwa, Sylvie Ramboz, Michelle Day, Jyothisri Kondapalli, D. James Surmeier, Fyodor D. Urnov, Philip D. Gregory, Edward J. Rebar, Ignacio Muñoz-Sanjuán, H. Steve Zhang - Nature Medicine 2019 cited by 220

  12. Toward eliminating HLA class I expression to generate universal cells from allogeneic donors

    Authors: Hiroki Torikai, Andreas Reik, Frank Soldner, Edus H. Warren, Carrie Yuen, Yuanyue Zhou, Denise L. Crossland, Helen Huls, Nicholas Littman, Ziying Zhang, Scott S. Tykodi, Partow Kebriaei, Dean A. Lee, Jeffrey C. Miller, Edward J. Rebar, Michael C. Holmes, Rudolf Jaenisch, Richard E. Champlin, Philip D. Gregory, Laurence J.N. Cooper - Blood 2013 cited by 305

  13. Generation of Isogenic Pluripotent Stem Cells Differing Exclusively at Two Early Onset Parkinson Point Mutations

    Authors: Frank Soldner, Josée Laganière, Albert Cheng, Dirk Hockemeyer, Qing Gao, R. Alagappan, Vikram Khurana, Lawrence I. Golbe, Richard H. Myers, Susan Lindquist, Lei Zhang, Dmitry Guschin, Lauren Fong, B. Joseph Vu, Xiangdong Meng, Fyodor D. Urnov, Edward J. Rebar, Philip D. Gregory, H. Steve Zhang, Rudolf Jaenisch - Cell 2011 cited by 743

  14. Targeted genome editing in human repopulating haematopoietic stem cells

    Authors: Pietro Genovese, Giulia Schiroli, Giulia Escobar, Tiziano Di Tomaso, Claudia Firrito, Andrea Calabria, Davide Moi, Roberta Mazzieri, Chiara Bonini, Michael C. Holmes, Philip D. Gregory, Mirjam van der Burg, Bernhard Gentner, Eugenio Montini, Angelo Lombardo, Luigi Naldini - Nature 2014 cited by 565

  15. Drug-regulated CD33-targeted CAR T cells control AML using clinically optimized rapamycin dosing

    Authors: Jacob Appelbaum, April E. Price, Kaori Oda, Joy Zhang, Wai‐Hang Leung, Giacomo Tampella, Dong Xia, Pauline Pl So, Sarah K. Hilton, Claudya Evandy, Semanti Sarkar, Unja Martin, Anne-Rachel Krostag, Marissa Leonardi, Daniel E. Zak, Rachael Logan, Paula Lewis, Secil Franke-Welch, Njabulo Ngwenyama, Michael Fitzgerald, Niklas Tulberg, Stephanie Rawlings-Rhea, Rebecca Gardner, Kyle M. L. Jones, Angelica Sanabria, William Crago, John C. Timmer, Andrew Hollands, Brendan P. Eckelman, Sanela Bilic, Jim Woodworth, Adam J. Lamble, Philip D. Gregory, Jordan Jarjour, Mark Pogson, Joshua A. Gustafson, Alexander Astrakhan, Michael C. Jensen - Journal of Clinical Investigation 2024 cited by 45

  16. Precise genome modification in the crop species Zea mays using zinc-finger nucleases

    Authors: Vipula K. Shukla, Yannick Doyon, Jeffrey C. Miller, Russell C. DeKelver, Erica A. Moehle, Sarah E. Worden, Jon Mitchell, Nicole L. Arnold, Sunita M. Gopalan, Xiangdong Meng, Vivian M. Choi, Jeremy M. Rock, Yingying Wu, George E. Katibah, Zhifang Gao, David McCaskill, Matthew A. Simpson, Beth Blakeslee, Scott A. Greenwalt, Holly J. Butler, Sarah J. Hinkley, Lei Zhang, Edward J. Rebar, Philip D. Gregory, Fyodor D. Urnov - Nature 2009 cited by 953

  17. An improved zinc-finger nuclease architecture for highly specific genome editing

    Authors: Jeffrey C. Miller, Michael C. Holmes, Jianbin Wang, Dmitry Guschin, Ya-Li Lee, Igor Rupniewski, Christian Beauséjour, Adam James Waite, Nathaniel Wang, Kenneth A Kim, Philip D. Gregory, Carl O. Pabo, Edward J. Rebar - Nature Biotechnology 2007 cited by 1,047

  18. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases

    Authors: Elena Pérez, Jianbin Wang, Jeffrey C. Miller, Yann Jouvenot, Kenneth A Kim, Olga Liu, Nathaniel Wang, Gary Lee, Victor V. Bartsevich, Ya-Li Lee, Dmitry Guschin, Igor Rupniewski, Adam James Waite, Carmine Carpenito, Richard G. Carroll, Jordan S. Orange, Fyodor D. Urnov, Edward J. Rebar, Dale Ando, Philip D. Gregory, James L. Riley, Michael C. Holmes, Carl H. June - Nature Biotechnology 2008 cited by 999

  19. Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer

    Authors: Elena Provasi, Pietro Genovese, Angelo Lombardo, Zulma Magnani, Pei-Qi Liu, Andreas Reik, Victoria A. Chu, David E. Paschon, Lei Zhang, Jürgen Kuball, Barbara Camisa, Attilio Bondanza, Giulia Casorati, Maurilio Ponzoni, Fabio Ciceri, Claudio Bordignon, Philip D. Greenberg, Michael C. Holmes, Philip D. Gregory, Luigi Naldini, Chiara Bonini - Nature Medicine 2012 cited by 444

  20. In vivo genome editing of the albumin locus as a platform for protein replacement therapy

    Authors: Rajiv P. Sharma, Xavier M. Anguela, Yannick Doyon, Thomas Wechsler, Russell C. DeKelver, Scott Sproul, David E. Paschon, Jeffrey C. Miller, Robert J. Davidson, David A. Shivak, Shangzhen Zhou, Julianne Rieders, Philip D. Gregory, Michael C. Holmes, Edward J. Rebar, Katherine A. High - Blood 2015 cited by 298

  21. Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells

    Authors: Megan D. Hoban, Gregory J. Cost, Matthew Mendel, Zulema Romero, Michael L. Kaufman, Alok V. Joglekar, Michelle Ho, Dianne Lumaquin, David Gray, Georgia R. Lill, Aaron Cooper, Fabrizia Urbinati, Shantha Senadheera, Allen Zhu, Peiqi Liu, David E. Paschon, Lei Zhang, Edward J. Rebar, Andrew Wilber, Xiaoyan Wang, Philip D. Gregory, Michael C. Holmes, Andreas Reik, Roger P. Hollis, Donald B. Kohn - Blood 2015 cited by 320

  22. Ultracold polar molecules as qudits

    Authors: Rahul Sawant, Jacob A. Blackmore, Philip D. Gregory, Jordi Mur-Petit, Dieter Jaksch, J. Aldegunde, Jeremy M. Hutson, M. R. Tarbutt, Simon L. Cornish - New Journal of Physics 2019 cited by 158

  23. Sensitive and adaptable pharmacological control of CAR T cells through extracellular receptor dimerization

    Authors: Wai‐Hang Leung, Joel Gay, Unja Martin, Tracy E. Garrett, Holly M. Horton, Michael T. Certo, Bruce R. Blazar, Richard A. Morgan, Philip D. Gregory, Jordan Jarjour, Alexander Astrakhan - JCI Insight 2019 cited by 75

  24. Genetic engineering of human pluripotent cells using TALE nucleases

    Authors: Dirk Hockemeyer, Haoyi Wang, Samira Kiani, Christine S. Lai, Qing Gao, John P. Cassady, Gregory J. Cost, Lei Zhang, Yolanda Santiago, Jeffrey C. Miller, Bryan Zeitler, Jennifer M. Cherone, Xiangdong Meng, Sarah J. Hinkley, Edward J. Rebar, Philip D. Gregory, Fyodor D. Urnov, Rudolf Jaenisch - Nature Biotechnology 2011 cited by 1,144